Home About us Contact
|
Home About us Contact | ||
|
|
||
Attainable Goal (attainable + goal)
Selected AbstractsIs Evidence-Based Nursing Practice an Attainable Goal?JOURNAL OF OBSTETRIC, GYNECOLOGIC & NEONATAL NURSING, Issue 2 2006Nancy K. Lowe Editor No abstract is available for this article. [source] The African American Study of Kidney Disease and Hypertension (AASK) Trial: What More Have We Learned?JOURNAL OF CLINICAL HYPERTENSION, Issue 2 2003Domenic A. Sica MD The final results of the African American Study of Kidney Disease and Hypertension (AASK) have shown that the angiotensin-converting enzyme inhibitor ramipril was better than the , blocker metoprolol or the dihydropyridine calcium channel blocker amlodipine in slowing the rate of glomerular filtration rate decline in African American patients with mild to moderate renal insufficiency. Of note, there was no difference between the 92 mm Hg or less (lower group) and the 102,107 mm Hg (usual) mean arterial pressure groups as regards the secondary clinical composite end point. The secondary clinical composite end point in this study comprised a threshold drop of at least 50% or 25 mL/min in glomerular filtration rate, death, or reaching end-stage renal disease. The final results from this study would suggest that reduction in blood pressure to levels below those currently advocated for cardiovascular risk reduction, although a clearly attainable goal in this population, does not provide readily identifiable benefits to African Americans with hypertensive nephrosclerosis. Importantly, this study provides the basis for the primary use of angiotensin-converting enzyme inhibitors in an African American population with the characteristics of those studied in AASK. It remains to be determined if this represents a class effect for all angiotensin-converting enzyme inhibitors. [source] The criterion of consistency: Women's self-presentation at Yarmouk University, JordanAMERICAN ETHNOLOGIST, Issue 3 2010LAURA PEARL KAYA ABSTRACT In the late 20th century, for the first time, higher education became an attainable goal for Jordanian women of all backgrounds, and Jordanian universities became vibrant, coed public spaces. The first-generation-female college students who enter these spaces take relational traditions of female identity construction that developed in intimate settings and adapt them for use in large-scale, anonymous environments. Identities based on relationships are reified for exchange in a public sphere, and imperatives that had seemed to keep women in a "private" realm are transformed as women move in "public" space. After exploring the meanings of women's dress at Yarmouk University in Irbid, Jordan, I conclude with remarks on the implications of my study for the headscarf debate in France. [source] Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug,free remission in rheumatoid arthritis: Results from two large early arthritis cohortsARTHRITIS & RHEUMATISM, Issue 8 2009Diane van der Woude Objective Remission has become an attainable goal of rheumatoid arthritis (RA) treatment, especially since the advent of biologic antirheumatic therapy. Because little is known about patients who achieve disease remission with conventional treatment, we used 2 large independent inception cohorts to study the prevalence of and predictive factors for disease-modifying antirheumatic drug (DMARD),free sustained remission after treatment with conventional therapy. Methods Remission of disease was assessed in 454 patients from the Leiden Early Arthritis Clinic (EAC) and in 895 patients from the British Early Rheumatoid Arthritis Study (ERAS) who fulfilled the American College of Rheumatology 1987 revised criteria for the classification of RA and were treated with conventional therapy. Sustained DMARD-free remission was defined as fulfilling the following criteria for at least 1 year: 1) no current DMARD use, 2) no swollen joints, and 3) classification as DMARD-free remission by the patient's rheumatologist. Predictive factors were identified by Cox regression analysis. Results Sustained DMARD-free remission was achieved by 68 of 454 patients (15.0%) in the Leiden EAC and by 84 of 895 patients (9.4%) in the ERAS. Six factors were associated with sustained DMARD-free remission in both cohorts: acute onset, short symptom duration before inclusion, not smoking, little radiographic damage at baseline, absence of IgM rheumatoid factor (IgM-RF), and absence of HLA shared epitope alleles. In the ERAS, low disease activity at baseline was also predictive of remission. Multivariate analyses revealed symptom duration and the absence of autoantibodies (anti,cyclic citrullinated peptide 2 and IgM-RF) as independent predictors. Conclusion Sustained DMARD-free remission in RA patients treated with conventional therapy is not uncommon. Symptom duration at presentation and the absence of autoantibodies are associated with sustained DMARD-free remission. [source] Is "optimal" blood pressure an attainable goal?CLINICAL CARDIOLOGY, Issue 9 2002C. Richard Conti M.D., M.A.C.C. Editor-in-Chief No abstract is available for this article. [source] | ||||||||||